FDA Inspection 762066 — Brio Pharmaceuticals Inc
The FDA completed an inspection of Brio Pharmaceuticals Inc on January 12, 2012 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 12, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)